ERASED: Examining Racial and Socioeconomic Differences in Chronic Low Back Pain

Sponsor
Washington University School of Medicine (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05991440
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD) (NIH)
240
1
42
5.7

Study Details

Study Description

Brief Summary

The purpose of this research study is to gain a better understanding of how people's racial background and socioeconomic status (e.g., income, education, and employment) impact their experiences of chronic low back pain (cLBP).

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    240 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Racial and Socioeconomic Differences in Chronic Low Back Pain
    Anticipated Study Start Date :
    Dec 1, 2023
    Anticipated Primary Completion Date :
    Jun 1, 2025
    Anticipated Study Completion Date :
    Jun 1, 2027

    Outcome Measures

    Primary Outcome Measures

    1. To elucidate racial group disparities in clinical symptoms among NHBs and NHWs with cLBP. [two years]

      Clinical pain severity will be observed through quantitative sensory testing and self-reported questionnaires and surveys.

    2. To elucidate racial group disparities in experimental pain sensitivity among NHBs and NHWs with cLBP. [two years]

      Quantitative sensory testing equipment and biological markers assayed via blood samples.

    3. To elucidate racial group disparities in psychosocial risk factors, among NHBs and NHWs with cLBP. [two years]

      Psychosocial risk factors that will be observed will be greater increases in depressive symptoms, anxiety, and perceived stress, as well as greater social isolation and loneliness through the use of self-reported questionnaires and surveys.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion:
    • Non-specific cLBP that has persisted for at least 3 months and has resulted in pain on at least half the days in the past 6 months.

    • Age 18 - 85; the lower end of this age range was chosen to capture the growing prevalence of young adults with cLBP, and participants over 85 years are increasingly likely to meet one or more exclusion criteria.

    • Participants report ethnic group as non-Hispanic and racial group as either Black/African American or White/Caucasian.

    Exclusion:
    • Low back pain that is attributable to other factors such as ankylosing spondylitis, infection, malignancy, compression fracture of other trauma.

    • Systemic rheumatic disease/condition (e.g. rheumatoid arthritis, systemic lupus erythematosus, fibromyalgia).

    • Any other chronic pain condition that the participant believes to be more prominent or severe than the low back pain.

    • A history of clinically significant surgery to the low back within the past year.

    • Uncontrolled hypertension (i.e. SBP/DBP of > 150/95), cardiovascular or peripheral arterial disease.

    • Poorly controlled diabetes (HbA1c > 8%).

    • Neurological disease (e.g. Parkinson's, multiple sclerosis, epilepsy).

    • Serious psychiatric disorder requiring hospitalization within the past 12 months or characterized by active suicidal ideation.

    • Diminished cognitive function that would interfere with understanding of study procedures.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Washington University School of Medicine Saint Louis Missouri United States 63110

    Sponsors and Collaborators

    • Washington University School of Medicine
    • National Institute on Minority Health and Health Disparities (NIMHD)

    Investigators

    • Principal Investigator: Burel Goodin, PhD, Washington University School of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Burel Goodin, Prof of Anesthesiology, Washington University School of Medicine
    ClinicalTrials.gov Identifier:
    NCT05991440
    Other Study ID Numbers:
    • 202306132
    • R01MD017565
    First Posted:
    Aug 14, 2023
    Last Update Posted:
    Aug 14, 2023
    Last Verified:
    Aug 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Burel Goodin, Prof of Anesthesiology, Washington University School of Medicine
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 14, 2023